Publication | Closed Access
Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women
19
Citations
17
References
2014
Year
MDI therapy with detemir is a safe and effective alternative, with a good benefit-cost ratio compared to insulin pumps.
| Year | Citations | |
|---|---|---|
Page 1
Page 1